Laser Hair Removal for PCOS-Related Facial Hair
What laser can reduce, what it cannot treat, and why a long-term plan may include maintenance.
Laser can meaningfully reduce dark, coarse facial hair associated with PCOS and may reduce the time and psychological burden of frequent hair removal. It does not correct the underlying androgen or metabolic driver, so regrowth and maintenance are more likely than in a non-hormonal body area.
Reduction can be clinically and personally meaningful
An NHS teaching-hospital randomized trial compared five higher-fluence laser treatments with lower-fluence control treatments in women with PCOS-related facial hirsutism. Over six months, the higher-fluence group reported a larger fall in hair severity and time spent removing hair, alongside improvements in anxiety, depression and psychological quality of life.
A separate randomized split-face trial in 38 women with PCOS found Alexandrite laser produced longer hair-free intervals and larger hair-count reductions than the IPL system tested. These results support laser as a useful symptom treatment, but they do not mean every device, skin type or hair type will respond in the same way.
Laser treats follicles, not PCOS
PCOS can continue to recruit or thicken androgen-sensitive hairs over time. A successful course may substantially reduce the hairs present now while new terminal hairs later appear. For that reason, a realistic plan often separates an initial reduction course from occasional maintenance.
If facial hair is new, rapidly worsening, accompanied by voice change, scalp hair loss, severe acne, menstrual change or other symptoms, seek medical assessment rather than treating it as a cosmetic issue alone. A laser appointment is not a diagnostic test for PCOS or another endocrine condition.
Coordinate the underlying condition separately
One randomized trial found improved hirsutism control when metformin was combined with IPL in women with PCOS compared with IPL alone. That does not mean metformin is a hair-removal drug or that it is appropriate for everyone. Medicines for PCOS must be prescribed and monitored for their medical indications by an appropriate clinician.
Tell the laser clinic about hormonal medicines and any changes during the course. Treatment response may need to be judged over longer intervals, and maintenance expectations should be discussed before you buy a package.
Hair colour, thickness and skin tone still matter
Dark, coarse terminal hairs provide the clearest melanin target. Fine, blonde, red, grey and white hairs contain less useful target pigment and may respond poorly or not at all. Facial treatment also requires care because broad exposure of fine surrounding hair has been associated with paradoxical hair growth in some patients.
Skin tone guides wavelength and settings. For darker skin, 1064 nm Nd:YAG is often selected to create a wider safety margin at the epidermis. A patch test and close review of the exact area are essential.
Reviewed by Dr Nick
Dr Nick, Medical Director — GMC 6072251. This guide was clinically reviewed on 25 August 2026. It explains general evidence and cannot replace an assessment of your skin, hair, medicines and medical history.
Research used for this guide
- Randomized controlled trial of laser treatment among hirsute women with PCOS — facial-hair severity, time burden and psychological outcomes
- Randomized split-face comparison of Alexandrite laser and IPL in PCOS — hair counts, hair-free intervals and satisfaction after six treatments
- Metformin plus IPL versus IPL alone in PCOS — prospective randomized controlled trial; not a self-medication recommendation
- Laser and light-based therapies for hirsutism in PCOS — 2024 systematic review highlighting possible benefit and low certainty across heterogeneous studies
Study protocols, devices and patient groups differ. Percentages from one trial should not be read as a personal result guarantee.